2026 Semi-Annual Report Summary

Hua Lv Biotechnology Co Ltd·August 19, 2026·4 pages

✨ AI Summary

Jiangsu Hualv Bio-Tech Group Co., Ltd. reported a significant turnaround for the first half of 2026, with revenue reaching 693.88 million yuan and net profit attributable to shareholders of 46.10 million yuan. This represents a substantial improvement compared to the net loss recorded in the same period last year. The company also successfully completed the grant of its 2026 equity incentive plan to 31 participants.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

[Chart: Company logo]

Jiangsu Hualv Bio-Tech Group Co., Ltd.

2026 Semi-Annual Report Summary

I. Important Notes

This semi-annual report summary is derived from the full semi-annual report. To fully understand the company's operating results, financial position, and future development plans, investors should read the full semi-annual report on the media designated by the China Securities Regulatory Commission.

All directors attended the board meeting to review this report.

Non-standard audit opinion:

□ Applicable  Not applicable

Profit distribution plan or capital reserve conversion plan for the reporting period reviewed by the Board of Directors:

The company plans no cash dividends, no bonus shares, and no capital reserve conversion.

Preferred stock profit distribution plan for the reporting period approved by the Board of Directors:

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.